And CK/ALT is a potential biomarker for the differential evaluation of acute liver injury in dystrophic mice, which highlights the value to further evaluate the practice of CK/ALT in patients with dystrophinopathy. This evidence concerns the gene GPT and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.